The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer’s type (SDAT)
Abstract
Recent evidence indicates that curcumin (CUR), the principal curcuminoid of turmeric, exhibits antioxidant potential and protects the brain against various oxidative stressors. The aim of the present study was to examine the modulating impacts of CUR against cognitive deficits and oxidative damage in intracerebroventricular-streptozotocin (ICV-STZ) infused rats. Rats were injected bilaterally with ICV-STZ (3 mg/kg), while sham rats received the same volume of vehicle and then supplemented with CUR (80 mg/kg) for three weeks. After two weeks of ICV-STZ infusion, rats were tested for cognitive performance using passive avoidance and water maze tasks and then sacrificed for biochemical and histopathological assays. ICV-STZ rats showed significant cognitive deficits, which were significantly improved by CUR supplementation. CUR supplementation significantly augmented increased 4-hydroxynonenal (4-HNE) and malonaldehyde (MDA), thiobarbituric reactive substances (TBARS), hydrogen peroxide (H2O2), protein carbonyl (PC) and oxidized glutathione (GSSG); decreased levels of reduced glutathione (GSH) and its dependent enzymes (Glutathione peroxidase [GPx] and glutathione reductase [GR]) in the hippocampus and cerebral cortex; and increased choline acetyltransferase (ChAT) activity in the hippocampus of ICV-STZ rats. The study suggests that CUR is effective in preventing cognitive deficits, and might be beneficial for the treatment of sporadic dementia of Alzheimer's type (SDAT).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another experimental study showed that curcumin treatment restored learning and memory functions in the STZ model of AD by reducing the oxidative stress, enhancing ChAT activity and restoring insulin receptor protein [117,118].”
From Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment (2020) · cites this paper as [118]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
THE COLORIMETRIC DETERMINATION OF PHOSPHORUS
Fiske, C. H., & Subbarow, Y. (1925) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)84756-1 · Cited by 19,155
Free radicals in biology and medicine
Gutteridge, J. M. C. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Developments of a water-maze procedure for studying spatial learning in the rat
Morris, R. (1984) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(84)90007-4 · Cited by 7,180
Tietze, F. (1969) · Analytical Biochemistry · doi:10.1016/0003-2697(69)90064-5 · Cited by 6,077
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
[49] Determination of carbonyl content in oxidatively modified proteins
Levine, R. L., Garland, D. L., Oliver, C. N., Amici, A., Climent, I., Lenz, A.-G., Ahn, B. W., Shaltiel, S., & Stadtman, E. R. (1990) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(90)86141-h · Cited by 5,895
[42] Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal
Esterbauer, H., & Cheeseman, K. H. (1990) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(90)86134-h · Cited by 3,360
Jollow, D. J., Mitchell, J. R., ZAMPAGLIONE, N. G., & Gillette, J. R. (2008) · Pharmacology · doi:10.1159/000136485 · Cited by 3,291
Cited by
Sorted by citations
Inflammation in neurodegenerative diseases
Amor, S., Puentes, F., Baker, D., & Van Der Valk, P. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03225.x · Cited by 1,355
Kennedy, D. O., & Wightman, E. L. (2011) · Advances in Nutrition · doi:10.3945/an.110.000117 · Cited by 684
Lee, W., Loo, C., Bebawy, M., Luk, F., Mason, R. S., & Rohanizadeh, R. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311040002 · Cited by 552
Cox, K. H., Pipingas, A., & Scholey, A. B. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114552744 · Cited by 368
Javed, H., Khan, M. M., Ahmad, A., Vaibhav, K., Ahmad, M. E., Khan, A., Ashafaq, M., Islam, F., Siddiqui, M. S., Safhi, M. M., et al. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.02.046 · Cited by 367
Self-citationNaturally occurring phytochemicals for the prevention of Alzheimer’s disease
Kim, J., Lee, H. J., & Lee, K. W. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06562.x · Cited by 361
Abrahams, S., Haylett, W. L., Johnson, G., Carr, J. A., & Bardien, S. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.02.020 · Cited by 301
Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues
Brambilla, D., Droumaguet, B. L., Nicolas, J., Hashemi, S. H., Wu, L., Moghimi, S. M., Couvreur, P., & Andrieux, K. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.03.008 · Cited by 302
Chen, Y., Liang, Z., Blanchard, J., Dai, C., Sun, S., Lee, M. H., Grundke, I., Iqbal, K., Liu, F., & Gong, C. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8375-5 · Cited by 294
Khan, M. M., Ahmad, A., Ishrat, T., Khan, M. B., Hoda, M. N., Khuwaja, G., Raza, S. S., Khan, A., Javed, H., Vaibhav, K., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.02.031 · Cited by 279
Self-citationŠalković‐Petrišić, M., Knezović, A., Hoyer, S., & Riederer, P. F. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0877-9 · Cited by 281
Mahmood, K., Zia, K. M., Zuber, M., Salman, M., & Anjum, M. N. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.09.026 · Cited by 261
Voulgaropoulou, S. D., van Amelsvoort, T. A. M. J., Prickaerts, J., & Vingerhoets, C. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146476 · Cited by 243
Animal models in the drug discovery pipeline for Alzheimer's disease
Dam, D. V., & Deyn, P. P. D. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01299.x · Cited by 239
Neurotherapeutic applications of nanoparticles in Alzheimer’s disease
Sahni, J. K., Doggui, S., Ali, J., Baboota, S., Dao, L., & Ramassamy, C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.033 · Cited by 219
Alam, S., Mustafa, G., Khan, Z. I., Islam, F., Bhatnagar, A., Ahmad, F. J., & Kumar (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s35329 · Cited by 219
Self-citationCoradini, K., Lima, F. O., Oliveira, C. M., Chaves, P. S., Athayde, M. L., Carvalho, L. M., & Beck, R. C. R. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.04.009 · Cited by 200
Mehla, J., Reeta, K. H., Gupta, P., & Gupta, Y. K. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.09.006 · Cited by 192
Zhang, L. H., McClements, D. J., Wei, Z., Wang, G., Liu, X., & Liu, F. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1630358 · Cited by 191
Dong, S., Zeng, Q., Mitchell, E. S., Xiu, J., Duan, Y., Li, C., Tiwari, J. K., Hu, Y., Cao, X., & Zhao, Z. Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031211 · Cited by 179
Khan, M. B., Khan, M. M., Khan, A., Ahmed, M. E., Ishrat, T., Tabassum, R., Vaibhav, K., Ahmad, A., & Islam, F. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.07.025 · Cited by 165
Self-citationKamat, P. K., Kalani, A., Rai, S., Tota, S., Kumar, A., & Ahmad, A. S. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9384-y · Cited by 148
Self-citationNicotinamide mononucleotide inhibits JNK activation to reverse Alzheimer disease
Yao, Z., Yang, W., Gao, Z., & Jia, P. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.03.027 · Cited by 140
Therapeutic Potential of Turmeric in Alzheimer's Disease: Curcumin or Curcuminoids?
Ahmed, T., & Gilani, A. H. (2013) · Phytotherapy Research · doi:10.1002/ptr.5030 · Cited by 142
Obstacles against the Marketing of Curcumin as a Drug
Hassanzadeh, K., Buccarello, L., Dragotto, J., Mohammadi, A., Corbo, M., & Feligioni, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186619 · Cited by 149
Bassani, T. B., Turnes, J. M., Moura, E. L. R., Bonato, J. M., Cóppola-Segovia, V., Zanata, S. M., Oliveira, R. M. M. W., & Vital, M. A. B. F. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.08.014 · Cited by 134
Javed, H., Khan, M. M., Khan, A., Vaibhav, K., Ahmad, A., Khuwaja, G., Ahmed, M. E., Raza, S. S., Ashafaq, M., Tabassum, R., et al. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.072 · Cited by 133
Self-citationMuller, A. P., Ferreira, G. K., Pires, A. J., Silveira, G. D. B., de Souza, D. L., Brandolfi, J. D. A., de Souza, C. T., Paula, M. M. D. S., & Silveira, P. C. L. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.03.283 · Cited by 132
Ezz, H. S. A., Khadrawy, Y. A., & Noor, N. A. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0544-9 · Cited by 133
Curcumin and Resveratrol in the Management of Cognitive Disorders: What is the Clinical Evidence?
Mazzanti, G., & Giacomo, S. D. (2016) · Molecules · doi:10.3390/molecules21091243 · Cited by 131
Kennedy, D. O. (2014) · Advances in Nutrition · doi:10.3945/an.114.006320 · Cited by 128
Polyphenols in dementia: From molecular basis to clinical trials
Molino, S., Dossena, M., Buonocore, D., Ferrari, F., Venturini, L., Ricevuti, G., & Verri, M. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.07.021 · Cited by 119
Cognitive effects of vanillic acid against streptozotocin-induced neurodegeneration in mice
Singh, J., Kakalij, R. M., Kshirsagar, R., Kumar, B. H., Komakula, S., & Diwan, P. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2014.935866 · Cited by 108
Effects of turmeric on Alzheimer′s disease with behavioral and psychological symptoms of dementia
Hishikawa, N., Takahashi, Y., Amakusa, Y., Tanno, Y., Tuji, Y., Niwa, H., Murakami, N., & Krishna, U. (2012) · AYU (An International Quarterly Journal of Research in Ayurveda) · doi:10.4103/0974-8520.110524 · Cited by 121
Evaluation of imidacloprid-induced neurotoxicity in male rats: A protective effect of curcumin
Lonare, M. K., Kumar, M., Raut, S., Badgujar, P. C., Doltade, S., & Telang, A. G. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.09.004 · Cited by 116
Pleiotropic Protective Effects of Phytochemicals in Alzheimer's Disease
Davinelli, S., Sapere, N., Zella, D., Bracale, R., Intrieri, M., & Scapagnini, G. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/386527 · Cited by 114
Mehla, J., Gupta, P., Pahuja, M., Diwan, D., & Diksha, D. (2020) · Brain Sciences · doi:10.3390/brainsci10120964 · Cited by 108
Oxidative Stress in Alzheimer’s Disease: Should We Keep Trying Antioxidant Therapies?
Ferreira, M. E. S., de Vasconcelos, A. S., Vilhena, T. D. C., da Silva, T. L., Barbosa, A. D. S., Gomes, A. R. Q., Dolabela, M. F., & Percário, S. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0157-y · Cited by 112
Sarker, M. R., & Franks, S. F. (2018) · GeroScience · doi:10.1007/s11357-018-0017-z · Cited by 110
Amato, A., Terzo, S., & Mulè, F. (2019) · Antioxidants · doi:10.3390/antiox8120608 · Cited by 107
Giacomeli, R., Izoton, J. C., dos Santos, R. B., Boeira, S. P., Jessé, C. R., & Haas, S. E. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146325 · Cited by 109
Zhou, Q., Wang, M., Du, Y., Zhang, W., Bai, M., Zhang, Z., Li, Z., & Miao, J. (2015) · Annals of Neurology · doi:10.1002/ana.24361 · Cited by 105
Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer’s disease
Sun, Z., Yang, H., & Chen, S. (2013) · Translational Neurodegeneration · doi:10.1186/2047-9158-2-6 · Cited by 106
Hashemian, M., Anissian, D., Ghasemi‐Kasman, M., Akbari, A., Khalili-Fomeshi, M., Ghasemi, S., Ahmadi, F., Moghadamnia, A. A., & Ebrahimpour, A. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.025 · Cited by 106
Ahmed, M. E., Khan, M. M., Javed, H., Vaibhav, K., Khan, A., Tabassum, R., Ashafaq, M., Islam, F., Safhi, M. M., & Islam, F. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.02.006 · Cited by 103
Self-citationSquillaro, T., Cimini, A., Peluso, G., Giordano, A., & Melone, M. A. B. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.05.016 · Cited by 104
Siddiqi, K. S., Husen, A., Sohrab, S. S., & Yassin, M. O. (2018) · Nanoscale Research Letters · doi:10.1186/s11671-018-2638-7 · Cited by 104
Differential metformin dose-dependent effects on cognition in rats: role of Akt
Mostafa, D. K., Ismail, C. A., & Ghareeb, D. A. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4301-2 · Cited by 101
Zhou, S., Yu, G., Chi, L., Zhu, J., Zhang, W., Zhang, Y., & Zhang, L. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.07.007 · Cited by 100
Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs
Thakral, S., Yadav, A., Singh, V., Kumar, M., Kumar, P., Narang, R., Sudhakar, K., Verma, A., Khalilullah, H., Jaremko, M., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101960 · Cited by 103
Yang, W., Ma, J., Liu, Z., Lu, Y., Hu, B., & Yu, H. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1594-3 · Cited by 99
Pacheco, S. M., Soares, M. S. P., Gutierres, J. M., Gerzson, M. F. B., Carvalho, F. B., Azambuja, J. H., Schetinger, M. R. C., Stefanello, F. M., & Spanevello, R. M. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.02.014 · Cited by 99
Bassani, T. B., Bonato, J. M., Machado, M. M. F., Cóppola-Segovia, V., Moura, E. L. R., Zanata, S. M., de Oliveira, R. M. W., & Vital, M. A. B. F. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0645-9 · Cited by 91
Khuwaja, G., Khan, M. M., Ishrat, T., Ahmad, A., Raza, S. S., Ashafaq, M., Javed, H., Khan, M. B., Khan, A., Vaibhav, K., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.10.023 · Cited by 94
Self-citationLi, R., Cheng, X., Ye, M., Li, H., Zhang, X., & Guo, D. (2010) · Food Chemistry · doi:10.1016/j.foodchem.2010.12.014 · Cited by 92
Enhancement of transport of curcumin to brain in mice by poly(n-butylcyanoacrylate) nanoparticle
Sun, M. H., Gao, Y., Guo, C., Cao, F., Song, Z., Xi, Y., Yu, A., Li, A., & Zhai, G. (2010) · Journal of Nanoparticle Research · doi:10.1007/s11051-010-9907-4 · Cited by 92
Action Mechanisms of Curcumin in Alzheimer’s Disease and Its Brain Targeted Delivery
Ege, D. (2021) · Materials · doi:10.3390/ma14123332 · Cited by 97
Subash, S., Essa, M. M., Al-Asmi, A. R., Al‐Adawi, S., Vaishnav, R., Braidy, N., Manivasagam, T., & Guillemin, G. J. (2014) · Journal of Traditional and Complementary Medicine · doi:10.4103/2225-4110.139107 · Cited by 90
Liu, A., Zhao, X. D., Li, H., Liu, Z., Liu, B., Mao, X., Guo, L., Bi, K., & Jia, Y. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.10.028 · Cited by 89
Awasthi, H., Tota, S., Hanif, K., Nath, C., & Shukla, R. (2010) · Life Sciences · doi:10.1016/j.lfs.2009.11.007 · Cited by 86
Neuroprotective effect of curcumin on okadaic acid induced memory impairment in mice
Rajasekar, N., Dwivedi, S., Tota, S., Kamat, P. K., Hanif, K., Nath, C., & Shukla, R. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.04.033 · Cited by 85
Dragicevic, N., Delic, V., Cao, C., Copes, N., Lin, X., Mamcarz, M., Wang, L., Arendash, G. W., & Bradshaw, P. C. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.08.018 · Cited by 85
Joseph, A., Wood, T. R., Chen, C., Corry, K. A., Snyder, J. M., Juul, S. E., Parikh, P., & Nance, E. A. (2018) · Nano Research · doi:10.1007/s12274-018-2104-y · Cited by 79
Curcuminoids and resveratrol as anti-Alzheimer agents
Villaflores, O. B., Chen, Y., Chen, C., Yeh, J., & Wu, T. (2012) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2012.09.005 · Cited by 79
Hippocampal Neurogenesis in Alzheimer's Disease: Is There a Role for Dietary Modulation?
Maruszak, A., Pilarski, A. M., Murphy, T., Branch, N., & Thuret, S. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-131004 · Cited by 78
Current perspectives on pharmacotherapy of Alzheimer's disease
Chopra, K., Misra, S., & Kuhad, A. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.520702 · Cited by 75
Samy, D. M., Ismail, C. A., Nassra, R. A., Zeitoun, T. M., & Nomair, A. M. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.046 · Cited by 73
Pharmacology of epigenetics in brain disorders
Narayan, P. J., & Dragunow, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00526.x · Cited by 67
Kandezi, N., Mohammadi, M., Ghaffari, M., Gholami, M., Motaghinejad, M., & Safari, S. (2020) · PubMed Central · doi:10.22088/ijmcm.bums.9.1.1 · Cited by 67
Akhtar, A., Bishnoi, M., & Sah, S. P. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.08.001 · Cited by 67
Noor, N. A., Ezz, H. S. A., Farrag, A. R. H., & Khadrawy, Y. A. (2012) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2012.03.026 · Cited by 63
Verma, V., Singh, D., & Reeta, K. H. (2020) · Brain Sciences · doi:10.3390/brainsci10120923 · Cited by 62
Xu, Q.-Q., Xu, Y., Yang, C., Tang, Y. C., Li, L., Cai, H.-B., Hou, B., Chen, H.-F., Wang, Q., Shi, X., et al. (2016) · BioMed Research International · doi:10.1155/2016/9852536 · Cited by 59
Bigford, G. E., & Rossi, G. D. (2014) · Advances in Nutrition · doi:10.3945/an.113.005264 · Cited by 61
Ashraf, K., Mujeeb, M., Ahmad, A., Amir, M., Mallick, M. N., & Sharma, D. (2012) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(12)60278-0 · Cited by 58
Self-citationNeuroprotective effect of Alpinia galanga (L.) fractions on Aβ(25–35) induced amnesia in mice
Chellammal, H. S. J., Alagarsamy, V., Diwan, P. V., Kumar, S. S., Nisha, J. C., & Reddy, Y. N. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.08.048 · Cited by 57
Hippocampal changes in STZ-model of Alzheimer’s disease are dependent on sex
Biasibetti, R., dos Santos, J. P. A., Rodrigues, L., Wartchow, K. M., Suardi, L. Z., Nardin, P., Selistre, N. G., Vázquez, D., & Gonçalves, C. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.08.057 · Cited by 64
Enhancement of Curcumin Bioavailability Via the Prodrug Approach: Challenges and Prospects
Bhuket, P. R. N., El-Magboub, A., Haworth, I. S., & Rojsitthisak, P. (2016) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-016-0377-7 · Cited by 56
Potential Enzymatic Targets in Alzheimer’s: A Comprehensive Review
Alam, J., & Sharma, L. K. (2018) · Current Drug Targets · doi:10.2174/1389450119666180820104723 · Cited by 56
Islam, F., Islam, M. R., Meem, A. F. K., Nafady, M. H., Islam, M. R., Akter, A., Mitra, S., Alhumaydhi, F. A., Emran, T. B., Khusro, A., et al. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.136020 · Cited by 55
Self-citationRetractedLehoczki, A., Fekete, M., Jarecsny, T., Zábó, V., Szappanos, Á., Csípő, T., Lipécz, Á., Major, D., Fazekas‐Pongor, V., Varga, P., et al. (2025) · Nutrients · doi:10.3390/nu17172884 · Cited by 65
Silva, T. G. D. S. E., de Paulo, M. E. F. D. V., da Silva, J. R. M., Alves, A. D. S., de Britto, L. R. G., Xavier, G. F., & Sandoval, M. R. L. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03281 · Cited by 59
Lu, Y., Li, T., Qureshi, H. Y., Han, D. C., & Paudel, H. K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.220962 · Cited by 54
Abdel-Wahhab, M. A., Salman, A. S., Ibrahim, M., El‐Kady, A. A., Abdel‐Aziem, S. H., Hassan, N. S., & Waly, A. I. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.06.005 · Cited by 53
Cocrystallization of Curcumin with Benzenediols and Benzenetriols via Rapid Solvent Removal
Wong, S. N., Hu, S., Ng, W. W., Xu, X., Lai, K. L., Lee, T. W.-Y., Chow, A. H. L., Sun, C. C., & Chow, S. F. (2018) · Crystal Growth & Design · doi:10.1021/acs.cgd.8b00849 · Cited by 53
Zarrouk, A., Hammouda, S., Ghzaiel, I., Hammami, S. O., Khamlaoui, W., Ahmed, S. H., Lizard, G., & Hammami, M. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666201203123046 · Cited by 52
Xu, Y., Mei, Y., Qu, Z.-L., Zhang, S., Zhao, W., Fang, J., Wu, J., Yang, C., Liu, S., Fang, Y., et al. (2018) · BioMed Research International · doi:10.1155/2018/4606752 · Cited by 50
Liu, C., Wu, Y., Zha, S., Liu, M., Wang, Y., Yang, G., Ma, K., Fei, Y., Zhang, Y., Hu, X., et al. (2015) · Brain Research · doi:10.1016/j.brainres.2015.11.040 · Cited by 48
Curcumin attenuates collagen-induced inflammatory response through the “gut-brain axis”
Dou, Y., Luo, J., Wu, X., Wei, Z., Tong, B., Yu, J., Wang, T., Zhang, X., Yang, Y., Yuan, X., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1047-7 · Cited by 50
Rasheed, N. O. A., Sayed, N. S. E., & El-Khatib, A. S. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.05.010 · Cited by 44
Pluta, R. M., Ułamek-Kozioł, M., & Czuczwar, S. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124002 · Cited by 46
Effect of Lactobacillus Fermentation on the Anti-Inflammatory Potential of Turmeric
Yong, C. C., Yoon, Y., Yoo, H., & Oh, S. (2019) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1906.06032 · Cited by 49
Zhang, X., Li, Y., & Hu, Y. (2020) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2020.125288 · Cited by 46
Involvement of PPAR-gamma in curcumin-mediated beneficial effects in experimental dementia
Rinwa, P., Kaur, B., Jaggi, A. S., & Singh, N. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0511-z · Cited by 45
Noor, N. A., Hosny, E. N., Khadrawy, Y. A., Mourad, I. M., Othman, A. I., Ezz, H. S. A., & Mohammed, H. S. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-021-00897-z · Cited by 45
Özkay, Ü. D., Can, Ö. D., Özkay, Y., & Öztürk, Y. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70878-2 · Cited by 43
Lü, C., Lv, J., Dong, L., Jiang, N., Wang, Y., Wang, Q., Li, Y., Chen, S., Fan, B., Wang, F., et al. (2018) · Phytotherapy Research · doi:10.1002/ptr.6044 · Cited by 43
Borre, Y. E., Panagaki, T., Koelink, P. J., Morgan, M. E., Hendriksen, H., Garssen, J., Kraneveld, A. D., Olivier, B., & Oosting, R. S. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.11.009 · Cited by 42
Mitochondria and Cellular Redox State on the Route from Ageing to Alzheimer's Disease
Abate, G., Vezzoli, M., Sandri, M., Rungratanawanich, W., Memo, M., & Uberti, D. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111385 · Cited by 41
Reisi, P., Arabpoor, Z., Hamidi, G. A., Rashidi, B., Shabrang, M., Alaei, H., Sharifi, M., Salami, M., & Dolatabadi, H. R. D. (2012) · Advanced Biomedical Research · doi:10.4103/2277-9175.100157 · Cited by 40
Metadata
- Authors
- Ishrat, T., Hoda, M. N., Khan, M. B., Yousuf, S., Ahmad, M., Khan, M. M., Ahmad, A., & Islam, F.
- Affiliations
- Emory University (US)
- Jamia Hamdard (IN)
- University of Pittsburgh (US)
- Corresponding author
- Islam, Fakhrul
- Venue
- European Neuropsychopharmacology
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 19
- Issue
- 9
- Pages
- 636-647
- ISSN
- 0924-977X (ISSN-L)
- OpenAlex
- W2028376455
- Cited by
- 230
- References
- 71
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 5 · 2023: 11 · 2022: 12 · 2021: 12 · 2020: 22 · 2019: 15 · 2018: 22 · 2017: 19 · 2016: 17 · 2015: 10 · 2014: 14 · 2013: 14 · 2012: 19
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Health and Family Welfare
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Curcumin's Biomedical Applications
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Keywords
- curcumin, cognitive impairment, neurodegeneration, streptozotocin-induced neurotoxicity, oxidative stress, antioxidant activity, hippocampus, cerebral cortex, choline acetyltransferase, glutathione, lipid peroxidation, neuroprotection
- MeSH terms
- Alzheimer Disease, Animals, Brain, Cerebral Cortex, Choline O-Acetyltransferase, Cognition, Curcumin, Disease Models, Animal, Hippocampus, Injections, Intraventricular, Male, Nerve Degeneration, Streptozocin, Time Factors, Rats, Wistar, Reactive Oxygen Species, Neuroprotective Agents, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
